98%
921
2 minutes
20
Background: The Community Preventive Services Task Force (CPSTF) has recommended several interventions that have been demonstrated to be effective at increasing vaccination coverage.
Objective: Conduct a systematic review to examine the costs of interventions designed to increase vaccination coverage among children and adolescents in the United States.
Data Sources: PubMed, EconLit, Embase, and Cochrane.
Study Eligibility, Participants, And Interventions: Peer-reviewed articles from January 1, 2009 to August 31, 2019.
Appraisal And Synthesis Methods: Studies were identified with systematic searches of the literature, reviewed for inclusion criteria, abstracted for data on intervention, target population, costs, and risk of bias. Cost measures were reported as costs per child in the target population, costs per vaccinated child, incremental costs per vaccinated child, and costs per vaccine dose administered. Results were stratified by intervention type, vaccine, and age group.
Results: Thirty-seven studies were identified for full-text review. Across all interventions and age groups, the cost per child ranged from $0.10 to $537.38, and the incremental cost per vaccinated child ranged from $6.52 to $5,098.57. Provider assessment and feedback interventions had the lowest (median) cost per child ($0.17) and a healthcare system-based combined intervention with multiple components had the lowest (median) incremental cost per vaccinated child ($26.65). A community-based combined intervention with multiple components had the highest median cost per child ($537.38) and the highest median incremental cost per vaccinated child ($5,098.57).
Limitations: A small number of included intervention types and inconsistent cost definition.
Conclusions: There is substantial variability in the costs of CPSTF-recommended interventions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998236 | PMC |
http://dx.doi.org/10.1016/j.acap.2020.11.015 | DOI Listing |
J Sch Nurs
September 2025
Department of Women's and Children's Health, Uppsala University, Akademiska Hospital, Uppsala, Sweden.
This study investigated Swedish school nurses' experiences, self-perceived knowledge, and attitudes towards HPV vaccination. A cross-sectional repeated questionnaire study was conducted. The results were compared to a previous study conducted in 2016.
View Article and Find Full Text PDFHum Vaccin Immunother
December 2025
Merck & Co. Inc., Rahway, NJ, USA.
Invasive disease caused by type b (Hib) is a major health concern, particularly in children under 5 years of age and vulnerable populations. Use of Hib conjugate vaccines has significantly reduced the incidence of Hib disease. Among these, the polyribosylribitol phosphate-outer membrane protein complex (PRP-OMPC) conjugate has demonstrated uniquely robust immunogenicity in infants compared to PRP conjugated to tetanus toxoid.
View Article and Find Full Text PDFFront Pediatr
August 2025
Department of Pediatrics and Child Health Nursing, Wachemo University, Hosanna, Ethiopia.
Background: Millions of children, particularly in low and middle-income countries, are deprived of a comprehensive vaccination schedule. The advent of the COVID-19 pandemic exacerbated this issue by significantly disrupting vaccination schedules and other critical health initiatives. In light of this challenge, our study sought to evaluate vaccination coverage and identify its determinants among children aged 12-23 months in southern Ethiopia during the COVID-19 pandemic.
View Article and Find Full Text PDFDiscov Viruses
August 2025
Department of Mathematics, Indian Institute of Technology, Bombay, Mumbai, Maharashtra 400076 India.
Introduction: Outbreaks of measles have been frequently reported despite the availability of an effective vaccine. In this systematic review we examine the potential factors that could impact the effectiveness, efficacy and immunogenicity of the measles vaccine (MV) in children.
Methods: We conducted a literature search using PubMed and Google Scholar for primary articles published between January 2010 and April 2025.
Front Cell Infect Microbiol
September 2025
State Key Laboratory of Vaccines for Infectious Diseases, Xiang-An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China.
infections represent a significant public health concern. Despite their clinical relevance, the genetic determinants underlying bacterial fitness and virulence remain incompletely characterized. In this study, we systematically identified genes involved in host adaptation by generating a transposon mutant library and integrating a infection model with transposon sequencing (Tn-seq) technology.
View Article and Find Full Text PDF